{"meshTags":["Biomarkers, Tumor","Biopsy","Humans","Lymph Nodes","Melanoma","Neoplasm Invasiveness","Neoplasm Metastasis","Polymerase Chain Reaction","Skin Neoplasms"],"meshMinor":["Biomarkers, Tumor","Biopsy","Humans","Lymph Nodes","Melanoma","Neoplasm Invasiveness","Neoplasm Metastasis","Polymerase Chain Reaction","Skin Neoplasms"],"publicationTypes":["Journal Article","Review"],"abstract":"This article reviews the use of selective lymphadenectomy, otherwise known as sentinel lymph node biopsy, as a clinical alternative in patients with malignant melanoma. This represents a compromise between the two traditional treatment modalities, elective lymph node dissection or observation of the regional nodal basin followed by therapeutic lymph node dissection once disease becomes clinically apparent.","title":"Lymphatic mapping and selective lymphadenectomy as an alternative to elective lymph node dissection in patients with malignant melanoma.","pubmedId":"9759580"}